Stocktoria
Milestone Pharmaceuticals Inc. MIST
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2019-05-09
Milestone Pharmaceuticals Inc. statistics & valuation
Market cap$154.4M
P / B3.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -55.5% | -55.0% | -79.3% | -78.4% | -35.8% |
| Return on equity | -151.0% | -315.8% | -355.9% | -88.0% | -38.1% |
| Debt / equity | 1.37× | 4.06× | 2.97× | — | — |
| Current ratio | 8.01 | 9.10 | 10.11 | 11.70 | 17.55 |
Source: SEC EDGAR filings · CIK 0001408443 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.